BIOT
Market cap | $0.00 |
---|---|
Enterprise Value | $-13,145.00 |
Dividend Yield | $0 (0%) |
Earnings per Share | $-0.42 |
Beta | 0 |
Outstanding Shares | 28,750,000 |
Return on Equity | - |
---|---|
Return on Assets | - |
Return on Invested Capital | - |
P/E Ratio | -24 |
---|---|
PEG | 409.36 |
Price to Sales | - |
Price to Book Ratio | 1.45 |
Enterprise Value to Revenue | - |
Enterprise Value to EBIT | 0 |
Enterprise Value to Net Income | -1 |
Total Debt to Enterprise | 0 |
Debt to Equity | 0 |
No data
No data
Biotech Acquisition Company, a blank check company formed for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or other similar business combination with one or more busin...